The Supplement & Peptide Truth Map: free, sourced guides
Free answers. Every rule carries a numbered reference that resolves to a named publisher, a date and a link, so you can check it yourself. Read the guide that matches your situation; the paid pack is named once, at the end, for the reader who wants the whole thing done tonight.
- FDA Guidance on Peptides? What the Agency Has Actually Published
Short answer: no single FDA guidance document on peptides exists. The FDA sorts each peptide into an approved drug, a compounded 503A article, or a supplement lane, regulator-quoted with dates. - Is BPC-157 FDA Approved? What the Regulators Actually Say
Short answer: no. USADA states BPC-157 is not approved for human clinical use by the FDA or any other global health authority; WADA names it on the S0 list. - Is BPC-157 Legal? The Four Lanes, Regulator-Quoted
Depends which lane. FDA has not approved it as a drug; WADA S0 prohibits it for tested athletes at all times; the UK's MHRA warns about unregulated online products. - BPC-157 Safety: What the Human and Animal Evidence Actually Shows
No comprehensive human safety trials exist for BPC-157 despite years of open sale. What two independent reviews, USADA and the FDA actually found, dated and sourced. - Is Examine.com Worth It? An Honest Comparison
Examine.com grades evidence by condition, not by your own shelf. Here is what it actually does, what ConsumerLab does instead, and who each one is worth paying for. - Which Supplements Should I Take? Answer It Goal-First
The graded map: five moves, one afternoon. List, goal, grade, flag, verdict; every grade carries its source, and the audit ends with keep / question / ask your doctor.
The guides are drawn from The Supplement & Peptide Truth Map. What the research actually supports for your goal (muscle, energy, sleep, testosterone support, longevity), which influencer claims are hype, a fill-in audit of the stack you already take, the doctor and bloodwork questions worth asking, and the plain-language evidence-and-legality map of the peptides everyone is discussing (BPC-157, TB-500, CJC/ipamorelin, grey-market GLP-1). Evidence-graded, every claim sourced. No doses, no protocols, no sourcing. $29 one-time, no subscription.